Article info

Download PDFPDF
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

Authors

  • R. SALANI The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • R. J. KURMAN The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MarylandDivision of Gynecologic Pathology, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • R. GIUNTOLI The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • G. GARDNER The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • R. BRISTOW The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • T.-L. WANG The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland PubMed articlesGoogle scholar articles
  • I.-M. SHIH The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MarylandDivision of Gynecologic Pathology, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Ritu Salani, MD, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287, USA. Email: rsalani1{at}jhmi.edu

Citation

SALANI R, KURMAN RJ, GIUNTOLI R, et al
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

Publication history

  • First published May 1, 2008.
Online issue publication 
May 01, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.